These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 8181527)

  • 1. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
    Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
    Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.
    Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A
    Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
    Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E
    Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model.
    ter Steege JC; van de Ven MW; Forget PP; Brouckaert P; Buurman WA
    Cytokine; 1998 Feb; 10(2):115-23. PubMed ID: 9512901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.
    Muchamuel T; Menon S; Pisacane P; Howard MC; Cockayne DA
    J Immunol; 1997 Mar; 158(6):2898-903. PubMed ID: 9058827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the release of cytokines and reduction of the shock syndrome induced by anti-CD3 monoclonal antibody in mice by interleukin-10.
    Donckier V; Flament V; Gérard C; Abramowicz D; Vandenabeele P; Wissing M; Delvaux A; Fiers W; Leo O; Velu T
    Transplantation; 1994 May; 57(10):1436-9. PubMed ID: 8197603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
    J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T; Hisadome M; Komatsu H
    J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma enhances tumor necrosis factor-alpha production by inhibiting early phase interleukin-10 transcription.
    Shakhov AN; Woerly G; Car BD; Ryffel B
    Eur Cytokine Netw; 1996 Dec; 7(4):741-50. PubMed ID: 9010676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
    Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
    Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH; Gouma DJ; Buurman WA
    J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness.
    Balkhy HH; Heinzel FP
    J Immunol; 1999 Mar; 162(6):3633-8. PubMed ID: 10092824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
    Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A; Ferrara P; Caput D
    Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production.
    Trepicchio WL; Bozza M; Pedneault G; Dorner AJ
    J Immunol; 1996 Oct; 157(8):3627-34. PubMed ID: 8871663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.